Active Pharmaceutical Ingredients
Rabeprazole Sodium EC Pellets are enteric-coated multiparticulate systems designed for the oral delivery of Rabeprazole Sodium, a potent proton pump inhibitor (PPI) widely used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, erosive esophagitis, and Zollinger–Ellison syndrome. These pellets are engineered to prevent degradation in the acidic environment of the stomach and to release the drug in the upper intestine, thereby ensuring optimal absorption and therapeutic efficacy.
| Component | Function |
|---|---|
| Rabeprazole Sodium | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres (Nonpareil Seeds) | Inert core substrate for layering the API |
| Hypromellose (HPMC 5cps/15cps) | Binder for drug layering |
| Magnesium Hydroxide | pH modifier (stabilizes rabeprazole during layering) |
| Hydroxypropyl Cellulose (HPC) | Seal coat and sub-coating polymer |
| Methacrylic Acid Copolymer (Eudragit L100-55 / L30D-55) | Enteric coating polymer |
| Triethyl Citrate (TEC) | Plasticizer for coating flexibility |
| Talc | Anti-adherent and suspension stabilizer |
| Colloidal Silicon Dioxide | Glidant, improves flowability |
| Isopropyl Alcohol / Purified Water | Solvent system (evaporates during processing) |
Salius Pharma’s Rabeprazole Sodium EC Pellets are manufactured in USFDA-approved, WHO-GMP, and ISO-compliant facilities, ensuring the highest standards of quality, safety, and compliance. Using advanced enteric coating and pelletization technology, our pellets provide:
• Robust gastric acid protection
• Precise delayed release for optimized intestinal absorption
• Customizable strength and particle size
• Excellent flowability and compressibility for ease in final dosage formulation
With comprehensive regulatory documentation (DMF, COA, MSDS, etc.), global export experience, and custom manufacturing capabilities, we support clients across regulated and semi-regulated markets including Africa, LATAM, MENA, and Southeast Asia.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Rabeprazole Sodium EC Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Our typical MOQ is 25 kg, suitable for formulation trials and initial commercial batches. However, we offer scalable supply solutions, including bulk packaging for large-scale production.
Yes. Rabeprazole Sodium EC Pellets are multi-particulate enteric-coated systems specifically designed for capsules, enteric tablets, and sachet-based dosage forms.
Yes. The pellets are manufactured under GMP-compliant conditions and are designed to meet global quality and stability requirements, making them suitable for export to regulated and semi-regulated markets.